source
- FDA delays AstraZeneca breast cancer drug camizestrant PDUFA dateThe U.S. Food and Drug Administration has extended the PDUFA target date for AstraZeneca’s breast cancer candidate camizestrant, pushing the review timeline back by a few days. No new deadline was…
- 23andMe partners with HealthEx to let users import medical records for a 360-degree health view23andMe announced a partnership with HealthEx that will let its customers import their medical records, creating a more complete view of personal health. The new feature will combine genetic data…